Begoña Colás

840 total citations
47 papers, 705 citations indexed

About

Begoña Colás is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Begoña Colás has authored 47 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in Begoña Colás's work include Neuroendocrine Tumor Research Advances (14 papers), Receptor Mechanisms and Signaling (10 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Begoña Colás is often cited by papers focused on Neuroendocrine Tumor Research Advances (14 papers), Receptor Mechanisms and Signaling (10 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Begoña Colás collaborates with scholars based in Spain, France and Italy. Begoña Colás's co-authors include Pilar López‐Ruiz, E. Arilla, Javier Rodríguez‐Ubreva, Ariel Cariaga-Martínez, Santiago Ropero, J.C. Angulo, Christiane Susini, Juan Carlos Prieto, José I. López and Nicole Vaysse and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Begoña Colás

47 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Begoña Colás Spain 16 467 138 132 92 86 47 705
Joaquim Calbó Spain 17 540 1.2× 463 3.4× 161 1.2× 87 0.9× 50 0.6× 23 1.1k
Patrick Joost Sweden 10 251 0.5× 146 1.1× 69 0.5× 43 0.5× 119 1.4× 13 584
Valérie Pawlowski France 12 404 0.9× 213 1.5× 36 0.3× 56 0.6× 141 1.6× 17 752
Sylvie Rodrigues-Ferreira France 14 445 1.0× 182 1.3× 37 0.3× 64 0.7× 74 0.9× 24 784
Per‐Erik Mansson United States 11 527 1.1× 62 0.4× 51 0.4× 102 1.1× 99 1.2× 18 822
Tomoyuki Nakano Japan 18 591 1.3× 88 0.6× 57 0.4× 48 0.5× 65 0.8× 54 843
Deborah A. Lazzarino United States 15 584 1.3× 215 1.6× 73 0.6× 36 0.4× 57 0.7× 19 872
T Sethi United Kingdom 17 542 1.2× 422 3.1× 217 1.6× 141 1.5× 323 3.8× 37 1.1k
Yi-Fen Lee United States 16 397 0.9× 91 0.7× 44 0.3× 56 0.6× 176 2.0× 20 740

Countries citing papers authored by Begoña Colás

Since Specialization
Citations

This map shows the geographic impact of Begoña Colás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Begoña Colás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Begoña Colás more than expected).

Fields of papers citing papers by Begoña Colás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Begoña Colás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Begoña Colás. The network helps show where Begoña Colás may publish in the future.

Co-authorship network of co-authors of Begoña Colás

This figure shows the co-authorship network connecting the top 25 collaborators of Begoña Colás. A scholar is included among the top collaborators of Begoña Colás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Begoña Colás. Begoña Colás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angulo, J.C., et al.. (2023). Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 24(1). 803–803. 5 indexed citations
2.
Angulo, J.C., C. Redondo, Manuel Sánchez‐Chapado, et al.. (2016). Survival predictors in patients with prostate adenocarcinoma with hormonal blockade. Pathology - Research and Practice. 212(10). 899–903. 3 indexed citations
3.
Angulo, J.C., et al.. (2016). A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy. Urologia Internationalis. 97(1). 16–25. 8 indexed citations
4.
García-Tello, A., J.C. Angulo, Javier Rodríguez‐Ubreva, et al.. (2014). Prostate anatomy in motheaten viable (me) mice with mutations in the protein tyrosine phosphatase SHP-1. Actas Urológicas Españolas (English Edition). 38(7). 438–444. 2 indexed citations
5.
García-Tello, A., J.C. Angulo, Javier Rodríguez‐Ubreva, et al.. (2014). Anatomía de la próstata en ratones motheaten viable (mev) con mutaciones en el gen de la proteína tirosina fosfatasa SHP-1. Actas Urológicas Españolas. 38(7). 438–444. 2 indexed citations
6.
Cariaga-Martínez, Ariel, Pilar López‐Ruiz, Omar Motiño, et al.. (2013). Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells. Cellular Signalling. 25(7). 1586–1597. 38 indexed citations
7.
Cariaga-Martínez, Ariel, María V.T. Lobo, Rosa M Martín Orozco, et al.. (2012). EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway. Carcinogenesis. 33(6). 1169–1177. 23 indexed citations
8.
López‐Ruiz, Pilar, et al.. (2011). SHP-1 in Cell-Cycle Regulation. Anti-Cancer Agents in Medicinal Chemistry. 11(1). 89–98. 58 indexed citations
9.
Ramón, Rosario, Pablo Martín‐Gago, Xavier Verdaguer, et al.. (2011). SSTR1‐ and SSTR3‐Selective Somatostatin Analogues. ChemBioChem. 12(4). 625–632. 13 indexed citations
10.
Martín‐Gago, Pablo, Rosario Ramón, Xavier Verdaguer, et al.. (2011). Fine‐tuning the π–π Aromatic Interactions in Peptides: Somatostatin Analogues Containing Mesityl Alanine. Angewandte Chemie International Edition. 51(8). 1820–1825. 19 indexed citations
11.
Rodríguez‐Ubreva, Javier, et al.. (2007). EGF Prevents the Neuroendocrine Differentiation of LNCaP Cells Induced By Serum Deprivation: The Modulator Role of P13K/Akt. Neoplasia. 9(8). 614–624. 40 indexed citations
12.
Ropero, Santiago, et al.. (2000). Modulation of Guanosine Triphosphatase Activity of G Proteins by Arachidonic Acid in Rat Leydig Cell Membranes1. Endocrinology. 141(3). 1093–1099. 6 indexed citations
13.
Oliva, José Luís, Guillermo Bodega, Antonio Chiloeches, et al.. (1997). Identification of a protein‐tyrosine phosphatase (SHP1) different from that associated with acid phosphatase in rat prostate. FEBS Letters. 406(1-2). 42–48. 18 indexed citations
14.
Colás, Begoña, et al.. (1995). Somatostatin receptor-effector system in rat pancreatic acinar membranes after subtotal enterectomy. American Journal of Physiology-Endocrinology and Metabolism. 268(2). E343–E348. 3 indexed citations
15.
Colás, Begoña, et al.. (1992). Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. European Journal of Biochemistry. 207(3). 1017–1024. 72 indexed citations
16.
Colás, Begoña, et al.. (1992). Somatostatin binding to a fresh rat astrocyte-enriched suspension. Neuropeptides. 23(1). 1–7. 10 indexed citations
17.
Barrios, Vicente, et al.. (1990). Effects of acute nicotine and mecamylamine administration on somatostatin concentration and binding in the rat brain. European Journal of Pharmacology. 179(3). 263–270. 11 indexed citations
18.
Colás, Begoña, Juan Carlos Prieto, & E. Arilla. (1990). Somatostatin binding to dissociated cells from rat cerebral cortex. Peptides. 11(6). 1109–1112. 20 indexed citations
19.
Colás, Begoña, et al.. (1989). Effects of insulin-induced hypoglycemia on somatostatin level and binding in rat cerebral cortex and hippocampus. Brain Research. 494(1). 36–41. 2 indexed citations
20.
Colás, Begoña, et al.. (1988). Partial enterectomy decreases somatostatin-binding sites in residual intestine of rabbits. Clinical Science. 74(5). 499–505. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joaquim Calbó Breakdown of academic impact, for papers by Patrick Joost Breakdown of academic impact, for papers by Valérie Pawlowski Breakdown of academic impact, for papers by Sylvie Rodrigues-Ferreira Breakdown of academic impact, for papers by Per‐Erik Mansson Breakdown of academic impact, for papers by Tomoyuki Nakano Breakdown of academic impact, for papers by Deborah A. Lazzarino Breakdown of academic impact, for papers by T Sethi Breakdown of academic impact, for papers by Yi-Fen Lee
Rankless by CCL
2026